Photoallergic dermatitis, however, is an immune response that can cause rashes, inflammation, and pain following sun exposure, even where the exposure is minimal.

Disclosures Dermatitis. 2011;22 (2):80-97. VH-rated Hypoallergenic Cosmetics and CCD Prevalence VMV Hypoallergenics in the Philippines has been following the VH rating system guidelines for 30 years.

Dermatitis. 2011;22 (2):80-97. Cosmetic Classification and Labeling The US FDA and most regulatory bodies worldwide classify products as cosmetics or drugs and do not recognize "cosmeceuticals." ...

Polymorphic light eruption (PMLE), commonly known as a sun rash or sun poisoning, is a type of photodermatosis triggered by an immune system reaction to the sun's ultraviolet (UV) radiation. Not ...

New data were recently published showing that SHR0302, better known as ivarmacitinib, is safe and effective to use in adolescent and adult patients against atopic dermatitis, the most common ...

Kymera Therapeutics, Inc. (NASDAQ:KYMR) on Monday revealed clinical results from the Phase 1 healthy volunteer study of KT-621, its first-in-class, oral STAT6 degrader medicine. The findings ...

Kymera Therapeutics, Inc. KYMR announced positive clinical results from the phase I study on the investigational candidate, KT-621. Shares surged as data surpassed the company’s expectations and ...

Atopic dermatitis can flare up any day of the year, causing scaly patches of extremely dry, itchy, inflamed skin. But for many people living with atopic dermatitis, commonly known as eczema, the ...

Sun Pharmaceutical Industries Limited announced top-line results from the phase 2 clinical trial evaluating the safety and efficacy of SCD-044 (a novel, orally bioavailable sphingosine-1- phosphate ...

The Phase 1b trial is designed to evaluate the safety, tolerability, pharmacokinetics, target engagement, and early signs of efficacy of ENV-294 in patients with moderate to severe atopic dermatitis.